FDA Says ADHD Med Adderall Is in Short Supply
THURSDAY, Oct. 13, 2022 -- People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.
The Adderall and Adderall IR... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 13, 2022 Category: General Medicine Source Type: news
America's Adderall shortage deepens: SEVENTH company warns it's running out of ADHD drug
Now seven pharmaceutical companies are reporting shortages of a common treatment for ADHD and narcolepsy. The shortage affects roughly 2.5 million Americans with ADHD. (Source: the Mail online | Health)
Source: the Mail online | Health - October 6, 2022 Category: Consumer Health News Source Type: news
DR MICHAEL MOSLEY: A breakthrough in insomnia drugs thanks to sleepy dogs!
DR MICHAEL MOSLEY: Like humans, dogs can spontaneously develop narcolepsy and I have seen some extraordinary footage of them running excitedly before suddenly collapsing into deep sleep. (Source: the Mail online | Health)
Source: the Mail online | Health - September 30, 2022 Category: Consumer Health News Source Type: news
How a man and his dogs discovered the cause of narcolepsy – podcast
The Breakthrough prizes are described by their Silicon Valley founders as ‘the Oscars of science’, and while they are not as glamorous, they do come with a $3m award. This year, one of the prizes was dished out to Prof Emmanuel Mignot at Stanford University and Masashi Yanagisawa at the University of Tsukuba for their work uncovering the cause of narcolepsy. Their dis covery has opened the door to the development of treatments for this chronic and often debilitating condition. Madeleine Finlay speaks to Mignot about how he pinpointed the cause of narcolepsy, why it is similar to diabetes and what sleep mysteries he wan...
Source: Guardian Unlimited Science - September 27, 2022 Category: Science Authors: Presented and produced by Madeleine Finlay, sound design by Rudi Zygadlo, and the executive producer was Danielle Stephens Tags: Science Medical research Health Genetics Biology Source Type: news
2023 Breakthrough Prizes Showcase Research in AI and Narcolepsy
Three prizes were awarded to six researchers working across the life sciences on cellular organization, protein structure, and the genetic underpinnings of a chronic sleep disorder. (Source: The Scientist)
Source: The Scientist - September 22, 2022 Category: Science Tags: News & Opinion Source Type: news
Stanford researcher's sleep disorders work delivers wake-up call for narcolepsy — and a Breakthrough Prize
Breakthrough Prize organizers — a tech glitterati that includes Facebook CEO Mark Zuckerberg, Google co-founder Sergey Brin, 23andMe founder and CEO Anne Wojcicki and venture capitalist Yuri Milner — awarded more than $15 million in prizes in its 11th year. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 22, 2022 Category: American Health Authors: Ron Leuty Source Type: news
Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression - Krystal AD, Benca RM, Rosenberg R, Schweitzer PK, Malhotra A, Babson K, Lee L, Bujanover S, Strohl KP.
Given the high rate of depression associated with narcolepsy or obstructive sleep apnea (OSA), this analysis compared effects of solriamfetol treatment of excessive daytime sleepiness (EDS) in participants with/without a history of depression (DHx+/DHx-). ... (Source: SafetyLit)
Source: SafetyLit - September 10, 2022 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
World champion athlete Nicola Barke beat narcolepsy that left her fast asleep in her birthday cake
At her birthday party, the then four-year-old Nicola Barke leaned forward to blow out the candles on her cake. What happened next did not follow the usual script. (Source: the Mail online | Health)
Source: the Mail online | Health - June 20, 2022 Category: Consumer Health News Source Type: news
When Sleep Becomes a Nightmare: My Struggle With Narcolepsy
Left untreated, narcolepsy can hold you back both socially and professionally, to say nothing of wreaking havoc on your mental health. (Source: WebMD Health)
Source: WebMD Health - April 5, 2022 Category: Consumer Health News Source Type: news
Woman reveals how rare sleep disorder has robbed her of 'so many years'
Helena Smythe, of Cambridgeshire, has idiopathic hypersomnia, a narcolepsy-like condition that is sometimes called 'excessive daytime sleepiness'. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2022 Category: Consumer Health News Source Type: news
Evaluating the risk of toxicity and adverse drug interactions involving recreational GHB use and prescribed drugs - Ricci G, Busard ò F, Gibelli F, Sirignano A, Brunetti P.
INTRODUCTION: : GHB is a small molecule and is present in the human CNS. Exogenously, GHB is administered orally in the form of sodium oxybate to treat cataplexy and excessive daytime sleepiness in patients with narcolepsy, and to manage alcohol withdrawal... (Source: SafetyLit)
Source: SafetyLit - January 21, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Comparing objective wakefulness and vigilance tests to on-the-road driving performance in narcolepsy and idiopathic hypersomnia - Bijlenga D, Urbanus B, van der Sluiszen NNJJM, Overeem S, Ramaekers JG, Vermeeren A, Lammers GJ.
Patients with narcolepsy or idiopathic hypersomnia (IH) are at increased risk of driving accidents. Both excessive daytime sleepiness, i.e. unwanted sleep episodes during the day, and disturbed vigilance are core features of these disorders. We tested on-t... (Source: SafetyLit)
Source: SafetyLit - November 15, 2021 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
Amphetamines and the privilege of being spared from sanction in road traffic due to medication - Mu ßhoff F, Skopp G, Madea B, Maas A.
On the one hand, amphetamine (racemic D,L-amphetamine, ratio 1:1) is used as an illegal drug; but on the other hand, especially D-amphetamine serves to treat narcolepsy and preferentially activity deficiency/ hyperactivity disorder (ADHD). Recently, in Ger... (Source: SafetyLit)
Source: SafetyLit - September 15, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
F.D.A. Approves Xywav, a GHB drug, for Rare Sleeping Disorder
Jazz Pharmaceuticals brought in more than $1.7 billion last year selling GHB to narcolepsy patients. With the new approval, sales could soar. (Source: NYT Health)
Source: NYT Health - August 14, 2021 Category: Consumer Health News Authors: Virginia Hughes Tags: Drugs (Pharmaceuticals) Sedatives Narcolepsy Sleep Food and Drug Administration Jazz Pharmaceuticals Inc Drug Abuse and Traffic Source Type: news
FDA Approves First Drug for Idiopathic Hypersomnia FDA Approves First Drug for Idiopathic Hypersomnia
Xywav, an oral solution of calcium, magnesium, potassium, and sodium oxybates, was approved last year for treating cataplexy or excessive daytime sleepiness in patients with narcolepsy.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - August 13, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
